Repligen Corp (NASDAQ:RGEN)

25.17
Delayed Data
As of 3:01pm ET
 -0.61 / -2.37%
Today’s Change
12.04
Today|||52-Week Range
26.89
+27.12%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close25.78
Today’s open26.82
Day’s range25.11 - 26.82
Volume116,830
Average volume (3 months)333,132
Market cap$843.6M
Dividend yield--
Data as of 3:01pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)+11.11%
Earnings growth (this year)-44.67%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+9.48%
P/E ratio69.9
Price/Sales6.34
Price/Book7.92

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-1.52-6.23%
FOLDAmicus Therapeutics ...-0.23-2.66%
OMEDOncoMed Pharmaceutic...-0.02-0.07%
SGNTSagent Pharmaceutica...-0.19-0.69%
Data as of 3:16pm ET, 03/06/2015

Financials

Last reporting dateMarch 6, 2015
EPS forecast (this quarter)$0.04
Annual revenue (last year)$68.2M
Annual profit (last year)$16.1M
Net profit margin23.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account